(647) 825-9895

©2019 by Designs that Cell.

10/2019

Savoy, S. K., & Boudreau, J. E. (2019). The Evolutionary Arms Race between Virus and NK Cells: Diversity Enables Population-Level Virus Control. Viruses, 11(10), 959.

The Evolutionary Arms Race between Virus and NK Cells: Diversity Enables Population-Level Virus Control

08/2019

Boudreau, J. E., Nersesian, S., Glazebrook, H., Toulaney, J., & Grantham, S. (2019). Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer. Frontiers in immunology, 10, 1782.

Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer

05/2019

Azad, T., Ghahremani, M., & Yang, X. (2019). The role of YAP and TAZ in angiogenesis and vascular mimicry. Cells, 8(5), 407.

The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry

01/2019

Akiyama, T. E., Skelhorne-Gross, G. E., Lightbody, E. D., Rubino, R. E., Shi, J. Y., McNamara, L. A., ... & Woods, J. W. (2019). Endothelial Cell–Targeted Deletion of PPARγ Blocks Rosiglitazone-Induced Plasma Volume Expansion and Vascular Remodeling in Adipose Tissue. Journal of Pharmacology and Experimental Therapeutics, 368(3), 514-523.

Endothelial Cell–Targeted Deletion of PPARγ Blocks Rosiglitazone-Induced Plasma Volume Expansion and Vascular Remodeling in Adipose Tissue

09/2019

Lusty, A. J., Hosier, G. W., Koti, M., Chenard, S., Mizubuti, G. B., Jaeger, M., & Siemens, D. R. (2019, September). Anesthetic technique and oncological outcomes in urology: A clinical practice review. In Urologic Oncology: Seminars and Original Investigations. Elsevier.

Anesthetic technique and oncological outcomes in urology: A clinical practice review

07/2019

Tutelman, P. R., Chambers, C. T., Urquhart, R., Fernandez, C. V., Heathcote, L. C., Noel, M., ... & MacLeod, J. (2019). When “a headache is not just a headache”: A qualitative examination of parent and child experiences of pain after childhood cancer. Psycho‐oncology, 28(9), 1901-1909.

When“a headache is not just a headache: A qualitative Examination of parent and child experiences of pain after childhood cancer

04/2019

Lepage, S. I., Robson, N., Gilmore, H., Davis, O., Hooper, A., St. John, S., ... & Koch, T. G. (2019). Beyond cartilage repair: the role of the osteochondral unit in joint health and disease. Tissue Engineering Part B: Reviews, 25(2), 114-125.

Beyond cartilage repair: the role of the osteochondral unit in joint health and disease

10/2018

Newsted, D., Banerjee, S., Watt, K., Nersesian, S., Truesdell, P., Blazer, L. L., ... & Craig, A. W. (2019). Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models.  Oncoimmunology, 8(2), e1539613.

Blockade of TGFβ signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models

08/2019

Koti, M., Chenard, S., Nersesian, S., Vidotto, T., Morales, A., & Siemens, D. R. Investigating the STING Pathway to Explain Mechanisms for BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications. Bladder Cancer, 1-10.

Investigating the STING Pathway to Explain Mechanisms for BCG Failures in Non-Muscle Invasive Bladder Cancer: Prognostic and Therapeutic Implications

06/2019

Vidotto, T., Nersesian, S., Graham, C., Siemens, D. R., & Koti, M. (2019). DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes. Journal for immunotherapy of cancer, 7(1), 148.

DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes

03/2019

Vitkin, N., Nersesian, S., Siemens, D. R., & Koti, M. (2019). The tumor immune contexture of prostate cancer. Frontiers in immunology, 10.

The tumor immune contexture of prostate cancer

04/2018

Clifford, C., Vitkin, N., Nersesian, S., Reid‐Schachter, G., Francis, J. A., & Koti, M. (2018). Multi‐omics in high‐grade serous ovarian cancer: Biomarkers from genome to the immunome. American Journal of Reproductive Immunology, 80(2), e12975.

Multi‐omics in high‐grade serous ovarian cancer: Biomarkers from genome to the immunome.